Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy

Ruling out advanced fibrosis/cirrhosis is mandatory for persons with hemophilia (PWH) who are candidates for gene therapy. However, clinical evaluation and noninvasive tests (NITs) may be inaccurate after hepatitis C virus (HCV) clearance. We conducted a prospective hepatological screening to detect...

Descripción completa

Detalles Bibliográficos
Autores principales: La Mura, Vincenzo, Bitto, Niccolò, Capelli, Cecilia, Caputo, Camilla, Siboni, Simona, Arcudi, Sara, Ciavarella, Alessandro, Gualtierotti, Roberta, Fracanzani, Anna Ludovica, Sangiovanni, Angelo, Peyvandi, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561041/
https://www.ncbi.nlm.nih.gov/pubmed/37505111
http://dx.doi.org/10.1182/bloodadvances.2023010723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561041/
https://www.ncbi.nlm.nih.gov/pubmed/37505111
http://dx.doi.org/10.1182/bloodadvances.2023010723

Ejemplares similares